Chytridiomycosis

Chytridiomycosis
Name	Chytridiomycosis
Field	Herpetology, Conservation biology
Symptoms	Skin sloughing, lethargy, anorexia, abnormal posture
Complications	Electrolyte imbalance, cardiac arrest
Onset	Variable
Duration	Variable
Causes	Batrachochytrium dendrobatidis, Batrachochytrium salamandrivorans
Risks	Global trade, habitat disturbance, climate variability
Diagnosis	Histology, Polymerase chain reaction, qPCR, environmental DNA
Prevention	Biosecurity, captive breeding, habitat protection
Treatment	Antifungal baths, temperature manipulation, supportive care

Chytridiomycosis is an infectious disease of amphibians caused by pathogenic fungus species that has driven declines and extinctions across multiple continents. First recognized in dramatic amphibian population collapses, it has become a focal issue for Conservation biology, Herpetology, IUCN assessments and transnational biosecurity policy. Research involves collaborations among institutions such as the Smithsonian Institution, World Wildlife Fund, University of California, Berkeley, and national wildlife agencies.

Introduction

Chytridiomycosis emerged as a conservation crisis following declines documented by researchers affiliated with Museum of Vertebrate Zoology, Australian National University, University of Colorado Boulder, Field Museum and others who linked declines to a novel pathogen. Attention from organizations including CITES, United Nations Environment Programme, Nature Conservancy and funding from agencies such as the National Science Foundation accelerated surveillance. High-profile media coverage by outlets like BBC News, The New York Times, Nature and Science raised awareness among policymakers in jurisdictions such as Australia, United States, Costa Rica, Panama and China.

Causes and Pathogens

Primary causative agents are the chytrid fungi Batrachochytrium dendrobatidis (Bd) and Batrachochytrium salamandrivorans (Bsal). Identification and taxonomy have involved mycologists and pathogen biologists at institutions like Royal Botanic Gardens, Kew, Natural History Museum, London, Max Planck Society laboratories and university departments including University of Exeter and University of Amsterdam. Pathogen emergence and spread have been linked to international trade in amphibians regulated by CITES, supply chains involving USFWS permits, and releases associated with hobbyist communities documented by NGOs such as Amphibian Ark and IUCN SSC Amphibian Specialist Group.

Pathophysiology and Symptoms

Infected amphibians exhibit epidermal disruption, hyperkeratosis and ion transport failure leading to hypokalemia and cardiac arrest; these mechanisms were elucidated by researchers at University of Wisconsin–Madison, Harvard University, University of Melbourne and Pasteur Institute. Clinical signs observed by field biologists at sites like Monteverde Cloud Forest Reserve, El Valle de Anton, Sierra Nevada and Bavarian Forest include skin sloughing, erythema, lethargy and abnormal posture. Laboratory studies using specimens from collections at Natural History Museum, Los Angeles County and American Museum of Natural History have correlated load measured by qPCR with morbidity and mortality.

Diagnosis and Detection

Diagnosis employs histopathology techniques developed by veterinary pathologists at Royal Veterinary College and molecular diagnostics such as qPCR protocols standardized by groups at University of Glasgow, Wageningen University, US Geological Survey and CDC. Environmental DNA (eDNA) surveys used in monitoring programs by agencies like European Environment Agency, BirdLife International partners and national park services enable noninvasive detection. Field diagnostics include skin swabs, histological staining evaluated by specialists at institutions like Cornell University and portable PCR devices trialed by teams in collaboration with WOAH programs.

Treatment and Management

Treatment strategies developed by veterinary teams at RSPCA clinics, university hospitals and conservation breeding centers (e.g., Durrell Wildlife Conservation Trust, ZSL) include topical antifungals (itraconazole), thermotherapy, supportive husbandry and rehydration. Ex situ management protocols and reintroduction plans have been coordinated by Amphibian Ark, IUCN SSC Amphibian Specialist Group and zoo networks such as AZA. Experimental therapeutics and probiotic approaches have been studied by teams at University of Kent, Smithsonian Tropical Research Institute and Pennsylvania State University with oversight from ethics committees at universities and national agencies.

Epidemiology and Impact on Amphibian Populations

Epidemiological investigations by researchers at Charles University (Prague), Pontificia Universidad Católica de Chile, University of Costa Rica, University of São Paulo and international consortia revealed rapid spread across Australia, Central America, Europe and parts of Asia. The crisis has contributed to documented extinctions and declines cataloged in assessments by IUCN Red List, conservation NGOs such as Global Wildlife Conservation and academic syntheses in PNAS. Notable affected taxa include species monitored by programs at FrogWatch USA, Amphibian Survival Alliance and regional conservation projects in Madagascar, Mexico and China.

Prevention, Control, and Conservation Measures

Prevention emphasizes biosecurity protocols implemented by agencies like DEFRA, DOI, Australian Department of Agriculture, Water and the Environment and park authorities at Yellowstone National Park and Kakadu National Park. Control measures include trade restrictions under CITES, captive assurance colonies run by ZSL and restoration planning by organizations such as NatureServe and BirdLife International partners. Conservation actions integrate habitat protection supported by programs at United Nations Development Programme and targeted reintroductions guided by standards from IUCN and managed by networks including AZA and Amphibian Ark.

Category:Amphibian diseases